As part of the local government’s initiative to identify, support, and promote successful start-up companies in and around the city of Aarhus, the Mayor, Nicolai Wammen, stopped by our offices last week and met with the founding brothers of CLC bio.
CEO at CLC bio, Thomas Knudsen - Mayor of Aarhus, Nicolai Wammen - CSO at CLC bio, Bjarne Knudsen
The meeting was very positive and the Mayor found the story and the strategies behind building CLC bio since 2005, very intriguing.
In coordination with CLC bio being recognized as a successful local startup in Aarhus - and now turned into a profitable global company with a massive growth and 98% export - our CEO, Thomas Knudsen, will present our story as a source of inspiration for all the new entrepreneurs, when the most promising new local startups are rewarded at the municipal hall on May 25th.
Together with PSSC Labs we have introduced a new turnkey solution for full-genome data analysis today: CLC Genomics Factory
Here’s a short 3-minute video introduction:
CLC Genomics Factory handles assembly, read mapping, and subsequent downstream analysis of very large amounts of high-throughput DNA and RNA sequencing data. Built as a high-performance bioinformatics appliance, CLC Genomics Factory comes in three different sizes with varying numbers of compute nodes, capable of processing the data output from up to 10 Illumina HiSeq2000 or 7 Life Technologies SOLiD 4 systems, as well as all other major high-throughput sequencing instruments.
We have had our upcoming de novo assembly algorithm in internal Alpha for some time now, and have just released an updated technical note with benchmarks from the Alpha 2 version, which is the version we’re currently running.
Impressive benchmarks
These new benchmarks are quite impressive: De novo assembly of a data set with 38 fold coverage of the human genome, completed in only 7 hours on a single computer, while also improving the overall quality!
Interested in trying this de novo assembler yourself?
Hopefully we can have the beta version out for public testing before Christmas - stay tuned! If you’re interested in more information, you can sign up here and get an invitation, once it’s released: Click to sign up for a beta trial of our de novo assembler
With Next Generation Sequencing (NGS) technologies, High Throughput Sequencing has become accessible to a much larger group of researchers. NGS technologies therefore have the potential to transform biomedical research and eventually also health care areas such as molecular diagnostics and personalized medicine.
However, High Throughput Analysis has not become commonly accessible yet, and therefore data analyses represents a serious bottleneck, which prevents scientists from reaching the full potential of the NGS technologies.
In these sessions, I will give you our perspective on the bioinformatics challenges arising from NGS data and how we are addressing these to make High Throughput Analysis accessible for all researchers. The session will include a presentation of the CLC Genomics Workbench software.
June 5th • Singapore
Thursday at 3:30 PM
Aspiration Theatre
Biopolis
June 6th • Kuala Lumpur
Friday at 3 PM
University of Malaya
Institute of Biological Sciences
Free access for all. Sign up by sending an e-mail with your name and organization to ngs@clcbio.com